How much nicotine in a day is too much?
No authority sets a daily limit on nicotine pouch use. The only official daily nicotine ceilings are on licensed medicines. What the sourced numbers actually are, and what each one measures.
No authority anywhere sets a daily limit on nicotine pouch use. The only official daily nicotine ceilings in existence are on licensed medicines — 15 pieces of 4 mg gum a day in the UK, 24 in the US. Every pouch law caps what is in the tin, not how many tins you get through.
This is one of those questions where the absence of an answer is the answer, and I think that is worth saying straight away rather than burying it. I went looking for a regulator, a health agency or a statute that puts a number on daily nicotine intake from pouches. There is none. What exists instead is a set of numbers that get quoted as if they answered the question and do not: a lethal dose that was wrong by a factor of ten, a food-contamination limit roughly a hundred times smaller than a single pouch, and a shelf of per-pouch content caps that say nothing about consumption at all.
So here is what the sourced numbers actually are, what each one measures, and where the honest edges of the evidence sit.
The ceilings that do exist are on medicines
If you want a number written by a regulator and attached to a daily total, you have to leave the pouch aisle and go to the pharmacy. Licensed nicotine replacement therapy carries a maximum daily dose because it is a medicine, and medicines carry posology.
The UK’s Summary of Product Characteristics for Nicorette 4 mg Gum, approved by the MHRA, states it in four words: “Maximum daily dose: 15 pieces per day.” That is 60 mg of nicotine content as a licensed ceiling. The 4 mg lozenge is the same arithmetic from the other direction — “Most patients require 8 to 12 lozenges per day, not to exceed 15 lozenges.”
The United States is more permissive. The FDA-approved Drug Facts label for a 4 mg nicotine polacrilex gum, published through DailyMed, instructs the user to “do not use more than 24 pieces a day”, and repeats it in capitals in the user’s guide. That is 96 mg a day. A 2 mg lozenge label caps use at “5 lozenges in 6 hours” and “no more than 20 lozenges per day”.
Two things follow. First, the same compound has two different official daily ceilings depending on which side of the Atlantic the label was approved on, which tells you how much judgement sits inside these numbers. Second, and this is the part that matters: no nicotine pouch has one, because no nicotine pouch is a licensed medicine. I searched the UK’s electronic Medicines Compendium, which holds every MHRA-approved product information document, for “pouch”, “snus”, “nicotine pouch” and “oral pouch”. Each returns “No search results”. Searching “nicotine” returns 48 products — gums, lozenges, a sublingual microtab, mouthsprays, a nasal spray, an inhalator, patches. Not a pouch among them. On the US side, FDA’s own list of approved and cleared cessation products runs “Skin patches”, “Chewing gum”, “Lozenges”, plus prescription spray and inhaler. No pouch.
What pouch law actually caps
Legislators have been busy on pouches for three years. Every instrument I can find regulates the object, not the person.
Denmark’s order on nicotine content in tobacco surrogates, BEK nr. 249 of 4 March 2025, in force from 1 July 2025, says that nicotine pouches “må maksimalt indeholde 9,0 mg nikotin pr. pose” — at most 9.0 mg of nicotine per pouch. It is a one-page instrument. It contains definitions, one content limit and a commencement date, and nothing whatsoever about quantity of use.
Finland took a different denominator. Laki 251/2025 prohibits a smokeless nicotine product containing “nikotiinia enemmän kuin 16,6 milligrammaa grammassa tuotetta” — more than 16.6 mg of nicotine per gram of product. Poland notified a draft to the Commission in January 2025 setting “a maximum nicotine content of 20 mg/g”.
Per pouch, per gram, per gram. None of it per day. The closest anyone comes to thinking about a daily total is the Dutch National Institute for Public Health and the Environment, whose risk assessments of pouches model one pouch — the exposure scenario is explicitly an adult using a single pouch. Even the body deriving a safe per-pouch content frames the question as what may be in one, never how many.
The one official daily figure, and why it is not about you
There is exactly one number I found that is both official and expressed per day, and it needs handling with care because out of context it is wildly misleading.
EFSA derived an acute reference dose for nicotine, and because nicotine does not accumulate indefinitely, set the acceptable daily intake at the same value. RIVM’s letter report 2025-0067 records the derivation:
“An oral Acute Reference Dose (ARfD) of 0.8 μg/kg bw was derived, based on a lowest observed adverse effect level (LOAEL) of 3.5 μg/kg bw for a slight increase in heart rate … Since nicotine does not accumulate in the body and its effects on the cardiovascular system are considered the most sensitive, EFSA equated the Acceptable Daily Intake (ADI) to the ARfD, setting it at 0.8 μg/kg bw per day.”
For a 70 kg adult that is 0.056 mg of nicotine per day — about six hundredths of a milligram, against 9 mg sitting in a single Danish-legal pouch.
Do not read that as “one pouch is 160 times the safe daily dose”, because that is not the question EFSA was answering. The ARfD is a food-contaminant value. It was derived to decide how much nicotine may permissibly turn up as a residue in wild mushrooms and dried spices, in food eaten by people who did not choose to consume nicotine and include infants. A deliberate, labelled dose taken by a consenting adult is a different exposure question with a different framework, and there is no regulatory instrument that applies the ARfD to a nicotine product. The mismatch is itself the lesson of this whole article: a number is only as good as the question it was built for.
RIVM’s work also explains why the only applicable Dutch figure was a food number — at the time of its assessment, pouches “vallen op dit moment onder de warenwet”, falling under commodities law and treated as a foodstuff rather than under the Tobacco Act.
The lethal dose you will see quoted is wrong
Sooner or later someone will tell you that 60 mg of nicotine kills an adult, which would make two pouches lethal. It is not true, and it has not been true for over a decade.
Bernd Mayer of Karl-Franzens University Graz traced the figure to its source in Archives of Toxicology in 2014 (PMID 24091634, funded by the Austrian Science Fund, no industry support declared). His finding was that the number came from “highly dubious self-experiments performed in the mid of the nineteenth century”, and that it was implausible on its face:
“The 60-mg dose would correspond to an oral LD50 of around 0.8 mg/kg, a dose that is considerably smaller than the values determined for laboratory animals, which are ranging from 3.3 (mice) to more than 50 mg/kg (rats).”
His own estimate, from clinical case material rather than Victorian self-dosing:
“Thus, a careful estimate suggests that the lower limit causing fatal outcomes is 0.5–1 g of ingested nicotine, corresponding to an oral LD50 of 6.5–13 mg/kg.”
Half a gram to a gram, not 60 mg. Roughly a factor of ten.
What I did not expect to find is that the figure Mayer demolished in 2014 is still in print in current official documents. The MHRA-approved Nicorette gum SPC, section 4.9, still reads: “The minimum lethal dose of nicotine in a non-tolerant man has been estimated to be 40 to 60 mg.” I would not put much weight on that line, and the same document’s own next sentence is the reason why — see below.
What actually happened when somebody did take too much in one day
There is one published human case that answers the headline question directly for pouches, and it is worth more than any amount of extrapolation.
Nicotine & Tobacco Research, 2025, PMID 39087735, from emergency physicians at the University of Toronto and St. Michael’s Hospital, who declared no conflicts of interest:
“Over the course of 12 hours, he consumed 15 extra-strength nicotine pouches (10.9 mg per pouch) as a study tool to prepare for the next-day exams. He presented to the emergency department with bizarre behavior requiring admission for persistent confusion and nausea which resolved after 24 hours.”
The authors call it “the first case of acute nicotine toxicity secondary to nicotine pouch use”. Fifteen pouches at 10.9 mg is 163.5 mg of nicotine content in half a day. He was confused, nauseated, admitted, and better in a day. It is one patient, and the figure is content rather than absorbed dose — perhaps half of it reached his bloodstream, on the extraction data below. But it puts a real marker on the map: well above the 96 mg US gum ceiling, well above the mythical 60 mg, and an order of magnitude below Mayer’s lethal threshold.
For what the body actually does on the way there, the Nicorette SPC’s overdose section is the best-sourced symptom list available, because it is a regulator’s: “nausea, vomiting, increased salivation, abdominal pain, diarrhoea, sweating, headache, dizziness, disturbed hearing and marked weakness.” The same section notes that an unaccustomed user has less margin — “Excessive consumption of this product by those who have not been in the habit of inhaling tobacco smoke or vaping could possibly lead to nausea, faintness or headaches.” For what to do when those signs turn up, and the official guidance on when to call someone, see signs of too much nicotine and what to do about it.
Why the number on the tin is not the number in you
Any attempt at a personal daily total runs into the fact that the printed content is not the delivered dose, and the gap is large and brand-dependent.
The German Federal Institute for Risk Assessment measured it directly (PMID 38841367, funded by BfR, no commercial relationships declared). Pouches declared at 6, 20 and 30 mg assayed at 4.8, 16.3 and 27.1 mg — “the pouches only contained between 80% and 90% of the declared nicotine content”. Mean doses actually extracted during use were 1.8, 4.7 and 14.1 mg respectively. A 6 mg pouch delivered under 2 mg.
Extraction fractions vary even more between products. Lunell and colleagues (PMID 32319528) found “the extracted fraction of nicotine for ZYN 8 mg (50%) was larger than for Longhorn Natural (19%)”. No funding statement is available in the accessible record for that paper, and one of its four authors was employed in Swedish Match’s Product Science function — ZYN’s manufacturer — which you should weigh accordingly.
Then there is accumulation. Neal Benowitz’s canonical account (PMID 19184645, NIDA-funded) gives nicotine a plasma half-life averaging about two hours, with a terminal half-life of around eleven hours measured by urinary excretion, and draws the conclusion that matters here:
“Thus, nicotine is not a drug to which smokers are exposed intermittently and which is eliminated rapidly from the body. On the contrary, smoking represents a multiple dosing situation with considerable accumulation while smoking and persistent levels for 24 h of each day.”
Pouches are a slower version of the same pattern — blood levels “rise gradually with the use of smokeless tobacco and plateau at about 30 min, with levels persisting and declining only slowly over 2 h or more”. Which means a daily total is not a sum of independent events. Three pouches spaced through a morning behave differently from three in an hour, and no label tells you that.
Why “too much” is personal, in a regulator’s own words
The single most useful sentence I found on this whole topic is in the Nicorette SPC, section 4.9:
“Adaptation to nicotine (e.g. in smokers/vapers) is known to significantly increase tolerability compared with non-smokers/vapers.”
That is a medicines regulator saying that the same dose is differently toxic depending on how accustomed you are. It is the structural reason nobody writes a universal daily number, and it is why I will not either. A twenty-a-day smoker and someone who has never used nicotine are not on the same scale, and the independent clinical evidence bears it out: in a Queen Mary University of London study (PMID 41384973, authors declaring no competing interests; no funding statement obtainable), “three participants who were light smokers experienced nausea and one vomited”, and the authors concluded that 9 mg pouches “may be too strong for light smokers”.
BfR’s independent trial reached the same place from the product side: the 30 mg pouches “had overall the strongest side effects and may induce addiction”, and because craving was reduced by weaker products too, “it is questionable whether such high nicotine contents should be allowed on the market”. Note what the regulator’s scientists asked for — a limit on content. Not on use.
The one number that is not about adults at all
There is a daily-dose question with an unambiguous answer, and it concerns children rather than users. An analysis of 134,663 nicotine ingestions by children under six reported to US poison centres between 2010 and 2023, published in Pediatrics in July 2025 (PMID 40658193, from Nationwide Children’s Hospital and Ohio State; no conflict-of-interest statement is available in the accessible record), found that “the rate of nicotine pouch ingestions increased by 763.1% from 2020 to 2023”, and that pouches were “more likely to be associated with a serious medical outcome” than other nicotine formulations combined.
Context, because the headline figure travels badly without it: most ingestions in the series produced no effect or a minor one, 81.3% needed no treatment at a healthcare facility, and the overall nicotine-ingestion rate actually fell 34.1% from 2015 to 2023. It is the pouch share specifically that rose. Across the whole fourteen-year dataset there were 39 ingestions with major effects and two deaths. The Nicorette SPC puts the mechanism in one line: “Doses of nicotine tolerated by adult and adolescent smokers or vapers can produce severe toxicity in children that may be fatal.” Cans are child-resistant for a reason, and the reason is measurable.
The numbers, side by side
| Figure | Value | What it actually measures | Source |
|---|---|---|---|
| UK licensed daily maximum, 4 mg gum | 15 pieces → 60 mg/day | Posology of a licensed medicine | MHRA-approved SPC |
| US labelled daily maximum, 4 mg gum | 24 pieces → 96 mg/day | FDA-approved OTC Drug Facts label | DailyMed SPL |
| US labelled daily maximum, lozenge | 20 lozenges | Same | DailyMed SPL |
| EFSA acceptable daily intake | 0.8 μg/kg bw/day (≈0.056 mg at 70 kg) | Permissible nicotine contamination of food | EFSA via RIVM 2025-0067 |
| Denmark, statutory cap | 9.0 mg per pouch | Content of one pouch | BEK nr. 249 of 2025 |
| Finland, statutory cap | 16.6 mg per gram | Concentration by mass | Laki 251/2025 |
| Poland, notified draft | 20 mg per gram | Concentration by mass | TRIS 2025/0055/PL |
| Occupational exposure limit | 0.5 mg/m³ TWA [skin] | Airborne concentration at work | NIOSH / OSHA |
| “Minimum lethal dose” still in current labelling | 40–60 mg | A nineteenth-century estimate, superseded | Nicorette SPC §4.9 |
| Evidence-based lower lethal bound | 500–1,000 mg ingested | Fatal outcomes in clinical case material | Mayer 2014 |
| Documented pouch toxicity case | 15 × 10.9 mg = 163.5 mg in 12 h | One hospitalised patient, recovered | PMID 39087735 |
| Daily limit on pouch use | None exists | — | — |
Frequently asked questions
So is there really no safe daily number?
There is no official daily number for pouches, which is a different and more defensible statement. I checked Denmark, Finland, Poland, the Netherlands, the UK and the US; the instruments that exist all cap the product rather than the user. I have not surveyed every jurisdiction on earth, so I will not say “nowhere”. And no product in this category is safe at any quantity — the question here is about degree, not about a threshold below which nothing happens.
Can I use the NRT ceilings as a guide?
They are the only official daily figures that exist, so they are the natural reference point, and they are not interchangeable with pouches. NRT posology was set for a medicine used to stop smoking, at known delivery, under a licence. A pouch has no licence, no posology, and a delivered dose that can be half its printed content or less. Comparing the numbers is useful; treating one as permission for the other is not. If this matters to you personally, it is a conversation for a clinician who knows your history, not for an article.
Does a stronger pouch mean a bigger daily dose?
Not reliably, and that is a sourced finding rather than a hedge. A BAT-funded pharmacokinetic study reported that “plasma nicotine concentration was not associated with the nicotine contents of the NPs” (PMID 34923602, all authors employed by the manufacturer of two of the brands tested). Delivery depends on pH, free-nicotine fraction, pouch mass and how long you keep it in, which is covered in nicotine delivery versus nicotine content.
Why do the per-gram and per-pouch caps give opposite answers?
Because they divide by different things. A 6 mg ZYN in a 0.40 g pouch is 15 mg/g; an 11 mg ZYN ULTRA in a 0.8 g pouch is 13.75 mg/g. Under a per-gram cap the bigger-numbered product is the more compliant one. Strength caps by country and pouch weight versus nicotine content work through the arithmetic.
Sources
- Nicorette 4 mg Gum SPC and Nicorette Cools 4 mg Lozenge SPC, MHRA-approved, electronic Medicines Compendium.
- Nicotine polacrilex gum 4 mg and lozenge 2 mg FDA-approved labels, DailyMed.
- FDA, approved and cleared cessation products.
- BEK nr. 249 of 4 March 2025 (Denmark); Laki 251/2025 (Finland); TRIS notification 2025/0055/PL (Poland, draft).
- RIVM letter report 2025-0067, commissioned by the Dutch Ministry of Health, Welfare and Sport — the EFSA ARfD and ADI derivation.
- NIOSH Pocket Guide to Chemical Hazards: Nicotine — REL and PEL 0.5 mg/m³ TWA [skin], IDLH 5 mg/m³.
- Mayer B, Arch Toxicol 2014, PMID 24091634 — Austrian Science Fund (P24005, P24946).
- Benowitz NL, Hukkanen J, Jacob P, Handb Exp Pharmacol 2009, PMID 19184645 — NIDA/NCRR grants R01 DA002277, R37 DA002277, P30 DA012393, M01 RR000083.
- Mallock-Ohnesorg N et al., Front Pharmacol 2024, PMID 38841367 — funded by BfR, grant BfR-CPS-08-60-0102-02.P606; no commercial relationships declared.
- Lunell E et al., Nicotine Tob Res 2021, PMID 32319528 — funding not stated in the accessible record; one author employed by Swedish Match.
- McEwan M et al., Eur J Drug Metab Pharmacokinet 2022, PMID 34923602 — supported by British American Tobacco (Investments) Limited; all authors industry-employed or contracted.
- Przulj D et al., Psychopharmacology 2025, PMID 41384973 — Queen Mary University of London; no competing interests declared; funding statement not obtainable.
- Acute toxicity case report, Nicotine Tob Res 2025, PMID 39087735 — University of Toronto / St. Michael’s Hospital; no conflicts declared.
- Nicotine ingestions among young children 2010–2023, Pediatrics 2025, PMID 40658193 — Nationwide Children’s Hospital; no conflict-of-interest statement in the accessible record.
Related reading on this site: the complete mg guide, mg per pouch versus mg per gram, how many pouches are in a can, stepping down your strength, what TSNA numbers mean, and tobacco-free versus synthetic nicotine.
